Corneal cross-linking (CXL) is a curative approach to re-increase the mechanical stability of corneal tissue that is progressively decreasing as a result of corneal disease such as keratoconus or pellucid marginal degeneration. The procedure was developed by IROC co-founder Prof. Theo Seiler together with Prof. Eberhard Spoerl from Dresden. CXL treatment has proven its safety and effectiveness in clinical use for many years now.
CXL creates additional chemical bonds inside the weakened corneal stroma by means of highly localized photo-polymerisation. Consequently, the biomechanical stability of the tissue is re-increased and corneal transplantation can be avoided.
Learn more about CXL: